PortfoliosLab logoPortfoliosLab logo
ESPR vs. RING
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

ESPR vs. RING - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Esperion Therapeutics, Inc. (ESPR) and iShares MSCI Global Gold Miners ETF (RING). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ESPR achieves a -14.86% return, which is significantly lower than RING's -5.54% return. Over the past 10 years, ESPR has underperformed RING with an annualized return of -14.95%, while RING has yielded a comparatively higher 13.85% annualized return.


ESPR

1D
0.00%
1M
0.96%
YTD
-14.86%
6M
-18.18%
1Y
162.50%
3Y*
35.36%
5Y*
-34.62%
10Y*
-14.95%

RING

1D
3.20%
1M
-16.79%
YTD
-5.54%
6M
-4.18%
1Y
56.55%
3Y*
44.87%
5Y*
18.76%
10Y*
13.85%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ESPR vs. RING - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ESPR
Esperion Therapeutics, Inc.
-14.86%68.18%-26.42%-52.01%24.60%-80.77%-56.40%29.63%-30.13%425.88%
RING
iShares MSCI Global Gold Miners ETF
-5.54%164.72%15.98%12.29%-15.40%-7.46%24.98%49.92%-13.14%10.24%

Correlation

The correlation between ESPR and RING is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.13

Correlation (3Y)
Calculated over the trailing 3-year period

0.12

Correlation (5Y)
Calculated over the trailing 5-year period

0.09

Correlation (10Y)
Calculated over the trailing 10-year period

0.09

Correlation (All Time)
Calculated using the full available price history since Jun 26, 2013

0.08

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ESPR vs. RING — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ESPR
ESPR Risk / Return Rank: 8686
Overall Rank
ESPR Sharpe Ratio Rank: 8787
Sharpe Ratio Rank
ESPR Sortino Ratio Rank: 8888
Sortino Ratio Rank
ESPR Omega Ratio Rank: 8787
Omega Ratio Rank
ESPR Calmar Ratio Rank: 8484
Calmar Ratio Rank
ESPR Martin Ratio Rank: 8484
Martin Ratio Rank

RING
RING Risk / Return Rank: 3636
Overall Rank
RING Sharpe Ratio Rank: 3838
Sharpe Ratio Rank
RING Sortino Ratio Rank: 3434
Sortino Ratio Rank
RING Omega Ratio Rank: 3939
Omega Ratio Rank
RING Calmar Ratio Rank: 3636
Calmar Ratio Rank
RING Martin Ratio Rank: 3333
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ESPR vs. RING - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Esperion Therapeutics, Inc. (ESPR) and iShares MSCI Global Gold Miners ETF (RING). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ESPRRINGDifference
Sharpe ratioReturn per unit of total volatility

+0.56

Sortino ratioReturn per unit of downside risk

+1.24

Omega ratioGain probability vs. loss probability

1.36

1.23

+0.13

Calmar ratioReturn relative to maximum drawdown

3.07

1.59

+1.48

Martin ratioReturn relative to average drawdown

7.68

4.45

+3.23

ESPR vs. RING - Sharpe Ratio Comparison

The current ESPR Sharpe Ratio is 1.76, which is higher than the RING Sharpe Ratio of 1.20. The chart below compares the historical Sharpe Ratios of ESPR and RING, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ESPR vs. RING - Drawdown Comparison

The maximum ESPR drawdown since its inception was -99.37%, which is greater than RING's maximum drawdown of -79.47%. Use the drawdown chart below to compare losses from any high point for ESPR and RING.


Loading charts...

Drawdown Indicators


ESPRRINGDifference

Max Drawdown

Largest peak-to-trough decline

-99.37%

-79.47%

-19.90%

Max Drawdown (1Y)

Largest decline over 1 year

-53.19%

-35.72%

-17.47%

Max Drawdown (3Y)

Largest decline over 3 years

-80.94%

-35.72%

-45.22%

Max Drawdown (5Y)

Largest decline over 5 years

-97.16%

-47.94%

-49.22%

Max Drawdown (10Y)

Largest decline over 10 years

-99.10%

-52.04%

-47.06%

Current Drawdown

Current decline from peak

-97.27%

-30.03%

-67.24%

Average Drawdown

Average peak-to-trough decline

-69.99%

-47.36%

-22.63%

Ulcer Index

Depth and duration of drawdowns from previous peaks

21.30%

12.74%

+8.56%

Volatility

ESPR vs. RING - Volatility Comparison

The current volatility for Esperion Therapeutics, Inc. (ESPR) is 1.06%, while iShares MSCI Global Gold Miners ETF (RING) has a volatility of 16.83%. This indicates that ESPR experiences smaller price fluctuations and is considered to be less risky than RING based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ESPRRINGDifference

Volatility (1M)

Calculated over the trailing 1-month period

1.06%

16.83%

-15.77%

Volatility (6M)

Calculated over the trailing 6-month period

61.44%

39.11%

+22.33%

Volatility (1Y)

Calculated over the trailing 1-year period

92.66%

47.31%

+45.35%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

91.79%

36.81%

+54.98%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

84.61%

36.70%

+47.91%

Dividends

ESPR vs. RING - Dividend Comparison

ESPR has not paid dividends to shareholders, while RING's dividend yield for the trailing twelve months is around 0.89%.


PositionTTM20252024202320222021202020192018201720162015
ESPR
Esperion Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
RING
iShares MSCI Global Gold Miners ETF
0.89%0.84%1.43%2.01%2.29%2.38%0.83%0.83%0.70%0.42%1.41%0.96%

Frequently Asked Questions


ESPR and RING have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

RING has higher volatility (16.83%) compared to ESPR (1.06%). In terms of maximum drawdown, ESPR dropped -99.37% vs RING's -79.47%.

ESPR currently has the higher Sharpe Ratio (1.76 vs 1.20), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ESPR and RING

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer